- The company reported the positive results of the initial trial for Zofin in the first 10 COVID-19 patients treated with Zofin in India. The trial is being conducted with CWI India and showed all patients have recovered from their symptoms and were discharged from the hospital
- Based on the positive results, the trial will be expanded to additional 65 patients with the mod. to sev. COVID-19 and is expected to be completed by Jun’2021
- If the expanded trial will show similar results as an initial trial, Organicell and CWI India plan to file EUA with the ICMR to use Zofin in India as a treatment for COVID-19
Click here to read full press release/ article | Ref: Business Wire | Image: Business Wire
The post Organicell Reports the Expansion of its Trial for Zofin to Treat COVID-19 Patients in India first appeared on PharmaShots.